4,248 Shares in Astera Labs, Inc. $ALAB Acquired by Axxcess Wealth Management LLC

Key Points

• Axxcess Wealth Management LLC acquired 4,248 shares of Astera Labs, valued at approximately $384,000, during the second quarter.
• Insiders at Astera Labs, including COO Sanjay Gajendra and CEO Jitendra Mohan, sold significant amounts of stock, resulting in a total of 1,182,514 shares sold worth over $202 million in the last 90 days.
• Astera Labs reported a 149.5% increase in revenue year-over-year for their latest quarter, posting earnings of $0.44 per share, exceeding analysts' expectations.

Axxcess Wealth Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,248 shares of the company's stock, valued at approximately $384,000.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock worth $554,780,000 after acquiring an additional 85,846 shares during the last quarter. Alliancebernstein L.P. boosted its position in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after acquiring an additional 4,478,741 shares during the last quarter. Atreides Management LP boosted its position in Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the last quarter. Fred Alger Management LLC boosted its position in Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after acquiring an additional 179,638 shares during the last quarter. Finally, FengHe Fund Management Pte. Ltd. acquired a new stake in Astera Labs during the second quarter worth approximately $106,772,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the sale, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This trade represents a 25.31% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,182,514 shares of company stock worth $202,298,671. 12.50% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Zacks Research lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, October 6th. Bank of America assumed coverage on shares of Astera Labs in a report on Friday, October 3rd. They issued a "neutral" rating and a $230.00 price target on the stock. Stifel Nicolaus lifted their price target on shares of Astera Labs from $174.00 to $185.00 and gave the company a "buy" rating in a report on Friday. Susquehanna lifted their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Finally, Evercore ISI lifted their price target on shares of Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $162.06.

Astera Labs Trading Down 2.3%

Shares of ALAB stock opened at $159.80 on Friday. The company's fifty day simple moving average is $199.68 and its 200-day simple moving average is $128.30. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The company has a market cap of $26.56 billion, a PE ratio of 285.36, a P/E/G ratio of 3.98 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter last year, the firm posted $0.13 EPS. The business's revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.